University of Sheffield:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:University of Sheffield - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9291
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Sheffield (Sheffield University) is an educational service provider that offers undergraduate, postgraduate, research and certificate programmes. The university offers courses in various fields including arts and humanities, engineering, medicine, dentistry and health; social sciences. It also provides courses in the areas of accounting and financial management, civil and structural engineering, computer science, human communication sciences, neuroscience, biomedical science, automatic control and systems engineering, town and regional planning, among others. The university conducts various research and development activities. Sheffield University is headquartered in Sheffield, the UK.

University of Sheffield – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Sheffield, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Sheffield, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
University of Sheffield, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Mironid Enters into Co-Development Agreement with University of Sheffield 10
Diurnal Enters into Research Agreement with University of Sheffield 11
MedImmune Enters into Research Agreement with University of Sheffield 12
Blueberry Therapeutics Enters into Agreement with University of Sheffield and Sheffield Hallam University 13
Licensing Agreements 14
Diurnal Enters into Licensing Agreement with University of Sheffield for Oligonucleotide Therapy 14
University of Sheffield – Key Competitors 15
University of Sheffield – Key Employees 16
University of Sheffield – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Government and Public Interest 18
Aug 31, 2018: Liver disease drug could help restore cells damaged by Alzheimer’s 18
Aug 14, 2018: Alternative patient-controlled pain relief drug could significantly reduce the number of epidurals 20
Aug 03, 2018: Stem cell transplants to be used in treating Crohn’s disease 22
Jul 24, 2018: Ground breaking research into rare bone cancer funded by inspirational legacy 24
May 21, 2018: Sheffield scientists get £150K boost for pioneering dementia research 25
May 21, 2018: Our scientists receive £150,000 boost for pioneering dementia research 26
May 08, 2018: New study to investigate premedication combating children’s anxiety prior to general anaesthesia 27
Oct 22, 2017: Novel therapies for multi drug-resistant bacteria 29
Sep 05, 2017: Acceptance and Commitment Therapy for people with motor neuron disease 30
Jul 14, 2017: New gene therapy treatment routes for motor neurone disease uncovered in new University of Sheffield study 31
Other Significant Developments 32
Jul 06, 2018: Computer therapy can help people with aphasia find lost words 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
University of Sheffield, Pharmaceuticals & Healthcare, Key Facts 2
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Sheffield, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Sheffield, Deals By Therapy Area, 2012 to YTD 2018 8
University of Sheffield, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mironid Enters into Co-Development Agreement with University of Sheffield 10
Diurnal Enters into Research Agreement with University of Sheffield 11
MedImmune Enters into Research Agreement with University of Sheffield 12
Blueberry Therapeutics Enters into Agreement with University of Sheffield and Sheffield Hallam University 13
Diurnal Enters into Licensing Agreement with University of Sheffield for Oligonucleotide Therapy 14
University of Sheffield, Key Competitors 15
University of Sheffield, Key Employees 16
University of Sheffield, Subsidiaries 17

List of Figures
University of Sheffield, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Sheffield, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[University of Sheffield:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Zen Technologies Limited
    Zen Technologies Limited - Strategy, SWOT and Corporate Finance Report Summary Zen Technologies Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Aurinia Pharmaceuticals Inc (AUP):企業の財務・戦略的SWOT分析
    Summary Aurinia Pharmaceuticals Inc (Aurinia Pharmaceuticals), formerly known as Isotechnika Pharma Inc, develops and commercialization of therapies. The company pipeline product Voclosporin, is used for the treatment of lupus nephritis (LN) and focal segmental glomerularsclerosis (FSGS); and voclos …
  • Bio Pappel, S.A.B. de C.V.:企業の戦略・SWOT・財務情報
    Bio Pappel, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Bio Pappel, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Banco Davivienda Sa
    Banco Davivienda Sa - Strategy, SWOT and Corporate Finance Report Summary Banco Davivienda Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Suven Life Sciences Ltd (SUVEN):企業の財務・戦略的SWOT分析
    Summary Suven Life Sciences Ltd (Suven), formerly Suven Pharmaceuticals Pvt Ltd designs, develops, manufactures and supplies bulk actives, drug intermediates and fine chemicals. The company offers active pharmaceutical ingredient products which include aripiprazole, calcium acetate, divalproex sodiu …
  • Cegid Group SA (CGD):企業の財務・戦略的SWOT分析
    Cegid Group SA (CGD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • McBride plc (MCB):企業の財務・戦略的SWOT分析
    McBride plc (MCB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Consolidated Edison Inc (ED):電力:M&Aディール及び事業提携情報
    Summary Consolidated Edison, Inc. (Con Edison) is an investor-owned energy company that offers wide range energy related products and services through its subsidiaries. It operates regulated electricity, gas and steam businesses, and competitive energy businesses. Con Edison’s competitive energy bus …
  • Brickell Biotech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Brickell Biotech Inc (Brickell Biotech) is a pharmaceutical company that develops differentiated therapeutics for the treatment of skin diseases. The company offers pipeline product candidates such as BBI-4000, BBI-5000, BBI-2000, BBI-3000 and BBI -6000. Its product candidate BBI-4000 is an …
  • KT&G Corp:企業の戦略・SWOT・財務情報
    KT&G Corp - Strategy, SWOT and Corporate Finance Report Summary KT&G Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Transcontinental Inc. (TCL.A):企業の財務・戦略的SWOT分析
    Transcontinental Inc. (TCL.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Clean Energy Fuels Corp (CLNE):石油・ガス:M&Aディール及び事業提携情報
    Summary Clean Energy Fuels Corp (Clean Energy) is an oil and gas company that offers natural gas fuel transportation services. The company’s products fuels, liquefied natural gas, compressed natural gas, renewable natural gas, and bulk fuels. It also provides storage systems, compressors, dispensers …
  • RentPath LLC:企業の戦略的SWOT分析
    RentPath LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Advanced Proteome Therapeutics Corp (APC):企業の財務・戦略的SWOT分析
    Advanced Proteome Therapeutics Corp (APC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • NetSol Technologies, Inc. (NTWK):企業の財務・戦略的SWOT分析
    NetSol Technologies, Inc. (NTWK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Precision Drilling Corp (PD):石油・ガス:M&Aディール及び事業提携情報
    Summary Precision Drilling Corp (Precision) is a provider of onshore drilling and production services to exploration and production companies in the oil and natural gas industry. It offers contract drilling, well servicing and other support services to oil and natural gas exploration and production …
  • Polpharma SA-製薬・医療分野:企業M&A・提携分析
    Summary Polpharma SA (Polpharma) undertakes the research, manufacture and marketing of generic drugs, prescription drugs and over the counter medications. It provides drugs in cardiology, gastroenterology and neurology areas. The company also manufactures over the counter (OTC) medications, dietary …
  • Simplex Infrastructures Ltd:企業の戦略・SWOT・財務分析
    Simplex Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report Summary Simplex Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Bechtel Power Corporation:企業の戦略的SWOT分析
    Bechtel Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Hays plc:企業の戦略・SWOT・財務情報
    Hays plc - Strategy, SWOT and Corporate Finance Report Summary Hays plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆